Sign In

Avanish Vellanki

Cofounder, Chairman & CEO at Rain Oncology

Avanish Vellanki is the Co-founder, Chairman, and CEO of Rain Oncology, a biotechnology company focused on developing precision oncology therapies for cancer patients. He has over 20 years of experience in the healthcare and investment banking sectors, beginning his career in equity research at Bear Stearns & Co. in 2004, where he specialized in small and mid-cap biotechnology companies. Following that, he worked at Citigroup in global healthcare investment banking before transitioning to the biotechnology industry with roles at Proteolix and Aptose Biosciences.123

Education

Vellanki holds a Bachelor of Arts in Biology from Carleton College, a Master of Business Science in Biochemistry from the University of Minnesota, and an MBA in Finance and Strategy from the Carlson School of Management at the University of Minnesota.12

Leadership at Rain Oncology

Under Vellanki's leadership since its founding in 2017, Rain Oncology has focused on creating targeted therapeutics that address specific oncogenic drivers in cancer patients. The company emphasizes precision oncology strategies to enhance treatment outcomes by utilizing genetic biomarkers to guide therapy selection. Their lead product candidate is milademetan, an oral small molecule that targets the MDM2-p53 complex to reactivate p53, which plays a critical role in regulating cell growth and preventing cancer.25

Vellanki is passionate about improving treatment options for cancer patients and believes that innovation in drug development can significantly impact patient care. His leadership style is characterized by articulating a clear vision and fostering a collaborative environment among his team.34

Highlights

Executive Spotlight - Avanish Vellanki

Related Questions

What inspired Avanish Vellanki to transition from investment banking to biotechnology?
How does Avanish Vellanki's leadership style impact Rain Oncology's culture?
What are some of the key challenges Avanish Vellanki has faced in developing cancer therapies?
How does Rain Oncology's approach to precision oncology differ from other cancer treatment companies?
What recent advancements has Rain Oncology achieved under Avanish Vellanki's leadership?
Avanish Vellanki
Avanish Vellanki, photo 1
Avanish Vellanki, photo 2
Add to my network

Location

Fremont, California, United States